FH535,
FH535,
108409-83-2,
2,5-dichloro-N-(2-methyl-4-nitrophenyl)benzenesulfonamide,
beta-Catenin/Tcf Inhibitor, FH535,
FH 535,
N-(2-Methyl-4-nitrophenyl)-2,5-dichlorobenzenesulfonamide,
FH-535,
N-[2-methyl-4-nitrophenyl]-2,5-dichlorobenzenesulfonamide,
AC1MR7XJ,
CBMicro_011295,
C13H10Cl2N2O4S,
CHEMBL2363137,
SCHEMBL15318105,
CTK8E8253,
KS-00000XOH,
AOB6671,
DTXSID60392716,
EX-A388,
CHEBI:125569,
HMS3653N07,
BCP09634,
SMSF0005619,
ZINC4662683,
MFCD01212888,
s7484,
STK079761,
AKOS003980135,
CB14399,
CCG-208119,
CS-1538,
MCULE-8478896855,
SB19433,
AK474178,
BC600548,
FH535, >=98% (HPLC),
HY-15721,
QC-11591,
BIM-0011242.P001,
RT-011845,
A3413,
FT-0672020,
SW219729-1,
Y1329,
J3.583.203C,
W-5258,
J-002138,
BRD-K48112880-001-01-5,
-Catenin/Tcf Inhibitor, FH535,
|A-Catenin/Tcf Inhibitor, FH535,
ZINC04662683,
CID3463933,
A13795,
C575430,
FH535, 98%, a cell-permeable compound that inhibits Wnt/beta-catenin and PPAR - 10MG 10mg,